» Articles » PMID: 33399111

Nano-encapsulated (Willd.) Using Poly (D, L-lactide) Nanoparticles Educe Effective Control in Streptozotocin-induced Type 2 Diabetic Rats

Overview
Publisher Wiley
Specialty Biotechnology
Date 2021 Jan 5
PMID 33399111
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The therapeutics for type 2 diabetes mellitus has emerged in the current century towards nanomedicine incorporated with plant active compounds. In this study, loaded poly (D, L-lactide) (PLA) nanoparticles (NPs) were evaluated in vivo for their anti-hyperglycemic potency towards streptozotocin-induced type 2 diabetic rats. loaded PLA NPs were synthesised by the double solvent evaporation method using PLA polymer. The NPs were then characterised and administrated orally for 28 successive days to streptozotocin-induced diabetic rats. The PLA NPs had significant anti-diabetic effects which were equal to the existing anti-diabetic drug glibenclamide. The antidiabetic activity is due to the synergism of compounds present in stem extract of the plant which reduced the side effects and anti-diabetic.

Citing Articles

Effects of Tinospora cordifolia (giloy) on metabolic syndrome components: a mechanistic review.

Mansouri M, Imenshahidi M, Rameshrad M, Hosseinzadeh H Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39731594 DOI: 10.1007/s00210-024-03642-2.


Current Strategies and Potential Prospects for Nanoparticle-Mediated Treatment of Diabetic Nephropathy.

Liu C, Wu K, Gao H, Li J, Xu X Diabetes Metab Syndr Obes. 2022; 15:2653-2673.

PMID: 36068795 PMC: 9441178. DOI: 10.2147/DMSO.S380550.


Nephroprotective role of nanoencapsulated Tinospora cordifolia (Willd.) using polylactic acid nanoparticles in streptozotocin-induced diabetic nephropathy rats.

Ambalavanan R, John A, Selvaraj A IET Nanobiotechnol. 2021; 15(4):411-417.

PMID: 34694717 PMC: 8675778. DOI: 10.1049/nbt2.12030.

References
1.
Gou M, Zheng X, Men K, Zhang J, Zheng L, Wang X . Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery. J Phys Chem B. 2009; 113(39):12928-33. DOI: 10.1021/jp905781g. View

2.
Weiss C, Lorenz M, Landfester K, Mailander V . Cellular uptake behavior of unfunctionalized and functionalized PBCA particles prepared in a miniemulsion. Macromol Biosci. 2007; 7(7):883-96. DOI: 10.1002/mabi.200700046. View

3.
Alsuhaibani S, Khan M . Immune-Stimulatory and Therapeutic Activity of : Double-Edged Sword against Salmonellosis. J Immunol Res. 2018; 2017:1787803. PMC: 5727750. DOI: 10.1155/2017/1787803. View

4.
Kurup S, Bhonde R . Combined effect of nicotinamide and streptozotocin on diabetic status in partially pancreatectomized adult BALB/c mice. Horm Metab Res. 2000; 32(8):330-4. DOI: 10.1055/s-2007-978646. View

5.
Szkudelski T . The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res. 2002; 50(6):537-46. View